Pathogen Detection Patents: Top Companies & Filing Trends 2026
Pathogen Detection and Environmental Monitoring Patents
Filing kept climbing through the last complete year, up 29% from 150 filings in 2021 to 194 in 2024, with 2025 posting the highest count so far at 235. Filings rose from 174 in 2017 to a 2021-2024 gain of 29% (150 to 194), with 2025 reaching 235, the highest year on record so far. The 2026 figure of 51 is a partial year under the mid-2026 cut-off and should not be read as a decline.
- 1RGT UNIV OF CALIFORNIA3.6%
- 2DOVETAIL GENOMICS LLC2.0%
- 3AGENCY FOR SCI TECH & RES1.9%
- 4MESO SCALE TECH LLC1.9%
- 5CERNO BIOSCIENCE LLC1.7%
See the full pathogen detection and environmental monitoring analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in pathogen detection and environmental monitoring?
The ranking of 100 assignees in this dataset shows a leader with 133 records, but that is only 3.6% of the 3,745 records in scope. The top 5 combined reach 11.0% and the top 10 reach 18.4%, so no organisation controls a majority of the claim space. Most filers hold only a handful of records, and the practical implication is that freedom-to-operate work has to check a long tail rather than a short list of dominant players.
Is the number of patent filings in this field still growing?
Yes, based on the last fully complete filing window: 2021 to 2024 filings rose 29%, from 150 to 194. The 2025 figure of 235 looks like a further increase, but because publication typically lags filing by around 18 months, 2025 and especially 2026 counts (51 so far) are undercounted and will keep rising as more applications publish. Treat 2021-2024 as the reliable growth signal.
What technology areas dominate pathogen detection patent claims?
Material analysis and testing (IPC class G01N) appears in 67.4% of the 3,745 records, making it the single largest technical category, followed by enzyme- and DNA-based measurement (C12Q) at 28.0%. Microorganism and genetic engineering claims (C12N), lab apparatus (B01L) and nanotechnology applications (B82Y) are all present but each cover well under 10% of records. Because records can carry multiple IPC classes, these figures overlap rather than sum to 100%.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Pathogen Detection and Environmental Monitoring covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.